ATSA Independent Living Expo Grant Opportunity

No comments
Exhibitors for the ATSA Independent Living Expo, Perth and Melbourne, have received a boost with the shows being confirmed as approved events under the Australian Government’s Business Events Grants program.

The Grants program will provide potential businesses with financial assistance to attend and exhibit at approved expos, conferences or conventions throughout the year – including the ATSA Independent Living Expo. The program will support these businesses by providing grants between $10,000 and $250,000.

Established in response to the economic impact of the COVID-19 pandemic and lockdown, the $50 million Business Events Grants program was launched to empower the business events sector and help Australian companies participate in major business to business events in the 2021 calendar.

In late 2020, ATSA prepared their submission to have the ATSA Independent Living Expo recognised on the approved events list for the Business Events Grant. The application was successful and the shows are now on the Schedule of Approved Business Events.

Eligible exhibitors can apply and may be directly reimbursed for up to 50 per cent of the costs to attend or exhibit at this pre-approved event. Grants may cover event costs including travel, accommodation, marketing and promotional materials, exhibition registration, stand development, equipment hire, and networking functions.

“We are pleased that ATSA was able to support its members and exhibitors of the Independent Living Expo’s by gaining acceptance  on the Schedule of Approved Events for the Business Events Grants Program,” said David Sinclair, ATSA’s Executive Officer.
“After the forced delay of the ATSA Independent Living Expo’s in 2020, we are excited to be focused on reigniting these events and are looking forward to seeing our members at the shows”.

Eligible applicants can apply now. Applications close at 5pm on 30 March 2021 AEST, or when all funding has been allocated. Visit Business Events Grant Opportunity | to start your application.

Questions about grant applications, eligibility or the program guidelines should be directed to the Business Grants Hub by calling 13 28 46 or email





Melanie RobertsonATSA Independent Living Expo Grant Opportunity
read more
New Regulation Amendments to Personalised and Custom Medical Devices

New Regulation Amendments to Personalised and Custom Medical Devices

No comments

The Australian Government has made amendments to the regulation of personalised medical devices, including custom-made medical devices and 3D printed devices. This follows the Therapeutic Goods Administration (TGA) consultation processes conducted in 2017 and 2019. Copies of the submissions and a summary of the feedback to the consultations are available on the TGA website.

About the regulatory changes

Minister Hunt has agreed to delay the commencement of the Therapeutic Goods Legislation Amendment (2019 Measure No 1) Regulations 2019, Schedules 1, 2 and 3 that implement changes for a number of devices to be reclassified, modernised, to clarify and improve the way custom made devices and software as a medical device are regulated. This will delay commencement from 25 August 2020 to: 

  • 25 November 2021 for reclassification of certain devices (allowing commencement to be timed for six months after the changed date for implementation of new EU Medical Device Regulations),
  • 25 February 2021 for medical device software, and
  • 25 February 2021 for personalised medical devices (including 3D printed devices). 

Amended regulations

  • Updated definitions for personalised medical devices that allow for the distinction between different design and production methodologies, depending on the level of health professional oversight;
  • Improved TGA oversight of facilities that manufacture personalised medical devices;
  • Introduction of the concept of a Medical Device Production System (MDPS) and a related framework that allows healthcare professionals to produce personalised devices for treating their patients without the need for manufacturing certification;
  • Updates to the Essential Principles to clarify what information must be supplied (to patients) with a personalised medical device; and
  • Updates to the classification rule for medical devices that record diagnostic images to capture a broader range of technologies now being used for this purpose such as 3D-printed models.

An overview of the regulatory changes is also available on TGA website.

You may wish to sign up to TGA Updates in order to be notified of new web content as it becomes available.

More detail about the definitions and transition arrangements

There are now four different definitions; custom-made medical device, patient-matched devices, adaptable medical devices, and medical device production system (MDPS). Each of these categories will have specific requirements under the regulations as outlined below.

1.Custom-made devices

The current exemption for these devices will continue to apply if the new definition of “custom-made” comes into effect. The new requirements for custom-made devices (except where the request for manufacture from a health professional was made prior to this date), includes:

  • annual reporting of custom-made devices;
  • allowing the TGA to inspect production facilities;
  • documentation about the device to be retained for certain periods; and
  • manufacturers to provide information about each custom-made medical device to the intended recipient.

2.Patient-matched devices

Under the new definition, “patient-matched medical devices” (for those custom-made devices that will be patient-matched medical devices under the new definition), a transitional exemption provision will apply. Guidance on this notification procedure will be provided soon.

3.Adaptable medical devices

The regulation of adaptable medical devices will not change.

4.Medical device production system (MDPS)

The MDPS is a new category of medical device which will allow healthcare providers to produce personalised devices for treating their patients, without the need for manufacturing certification. MDPS can include devices such as 3D printers, associated software, and resin that is intended by its manufacturer to be used by a dentist to produce dental crowns. In these cases:

  • the MDPS itself will be treated as a medical device;
  • health professionals or persons within a healthcare facility who use the MDPS (e.g., a dentist) will not be classified as a manufacturer under the Therapeutic Goods Act 1989; and
  • sponsors will be able to include MDPS on the Australian Register of Therapeutic Goods (ARTG) after 25 August 2020.  

Compliance with the new regulations

Class I custom-made and patient-matched devices, refer to only therapeutic goods meeting the updated definition of custom-made devices and will continue to remain exempt under the amendments introduced to the Therapeutic Goods (Medical Devices) Regulations 2002. Transitional arrangements have been put in place to ensure that manufacturers and suppliers of what will become ‘patient-matched’ devices can continue to supply these devices while they apply for inclusion in the Australian Register of Therapeutic Goods (ARTG).

Accessing the transitional arrangements will extend the deadline for ARTG-inclusion to 1 November 2024. The TGA are currently finalising guidance around the changes and what manufacturers and suppliers need to do from here. This is will be published soon, if you have any questions on this matter please contact ATSA or the TGA directly.

In the meantime, the Medical device inclusion process section of the Australian Regulatory Guidelines for Medical Devices (ARGMD) is a great source of information and resources relevant to including a Class I device on the ARTG.

Some of these devices will require a conformity assessment depending on the classification that the device falls in. Manufacturers may already have suitable evidence of conformity assessment certification from comparable overseas regulators that will meet regulatory requirements. This includes the EU Medical Device Directive (MDD) or EU MDR conformity assessment certificates.

Amendments to the Essential Principles in the Australian Medical Device Regulations and their implementation are also proposed to be delayed for up to two years after the commencement of European Union Medical Device Regulation changes (i.e. May 2023) and IVD Medical Device Regulations – this is still to be confirmed by the European Parliament, but is likely to be May 2022, so two years after that date.

This would provide time for industry to adjust to the EU regulations and to allow consideration of similar changes in the Australian context and ensure that the transition in Australia is implemented effectively.

Further information about the reforms will continue to be published on the TGA’s website, with the TGA also working closely with stakeholders to identify opportunities for continued consultation on guidance material over the coming months.

Several submissions to the TGA 2019 consultation highlighted the issue of how assistive technology for people with disabilities would be considered under the regulatory changes. The TGA consultation on products used for and by people with disabilities examined possible changes to the excluded goods determination on assistive technologies.  Consultation closed in late October 2019, and submissions have been reviewed. Unfortunately, this work has been impacted by the COVID-19 situation. It is currently with TGA Legal Services and will be circulated to ATSA and other stakeholders for comment prior to submission to the Government for consideration of policy approval.

If you have any questions in relation to the information provided above please contact or

Robyn SmartNew Regulation Amendments to Personalised and Custom Medical Devices
read more
Where to Find the Latest COVID-19 Information

Where to Find the Latest COVID-19 Information

No comments

ATSA encourages all members to regularly visit the NDIS Commission coronavirus (COVID-19) information page, available here.

This page contains links to updates, training, alerts, and resources for NDIS participants and providers. This information is to inform and support NDIS providers to continue to deliver quality and safe supports and services to NDIS participants.

Robyn SmartWhere to Find the Latest COVID-19 Information
read more
Proposed Bill to Grant NDIS Commissioner Additional Banning Powers

Proposed Bill to Grant NDIS Commissioner Additional Banning Powers

No comments

The NDIS Amendment (Strengthening Banning Orders) Bill 2020 will soon be introduced to Parliament, with the intention of granting the NDIS Commissioner new powers. If passed, the NDIS Commissioner will have the legislative authority to prevent unsuitable people from working with NDIS participants. The details of the NDIS Amendment (Strengthening Banning Orders) Bill 2020 can be found here.

Key points if Bill is passed:

  • The NDIS Commissioner, who is responsible for regulating NDIS providers and enforcing the NDIS Code of Conduct, will be granted additional banning powers to prevent people who may pose a risk of harm to participants from entering or re-entering the NDIS
  • The NDIS Commissioner will be able to apply banning orders to people even if they are not currently working in the NDIS. This means workers who have left the NDIS, including where they have been fired due to unsuitable behaviour, can be banned from re-entering the field. The amendments also mean the NDIS Commissioner can use information from sources outside the NDIS, such as a person’s conduct in aged care or childcare work, to ban an unsuitable person from entering the NDIS in the first place.

Minister Roberts noted that Banning orders are at the extreme end of the NDIS Commissioner’s regulatory powers and are only used in the most serious of cases. The NDIS Quality and Safeguards Commission makes the details of providers and workers who have been banned publicly available in the NDIS Provider Register. People with disability, their supporters and providers can use the Register to check that the people they are engaging to deliver NDIS services have not had a banning order against them.

Robyn SmartProposed Bill to Grant NDIS Commissioner Additional Banning Powers
read more
Updated Rules for Imported Disability Vehicles to Comply with Australian Standards

Updated Rules for Imported Disability Vehicles to Comply with Australian Standards

No comments

Imported disability vehicles are now subject to updated rules ensuring that safety considerations are regulated to comply with Australian standards.  Changes have commenced to progressively roll out improvements as part of the new Road Vehicle Standards (RVS) legislation.

ATSA pressed the need for the application of Australian Standards for all imported disability vehicles early in 2018 through several submissions, to the Inquiry into the Road Vehicle Standards Bill 2018 and related bills. The problem was that importers of modified disability vehicles wanted an exemption to “Australian Safety Standards”, yet local vehicle builders/modifiers were required to comply with existing local standards.

ATSA’s main recommendation was:

ATSA does not believe that the intention of the legislation is to trade off safety for profit and recommends that Australian Standards are applied to all imported disability vehicles to ensure only safe product is sold into the Australian market.

After several years of hard work and representation by ATSA, new legislation has now been implemented, requiring all disability vehicles purchased in recent times, and into the future, will need to be compliant with Australian Standards. This is a great win for all who use these vehicles, recognising the need for equality under the law and ensuring that the personal safety of assistive technology users is protected as being as important as all other consumers in the broader community.

Road Vehicles Standards Australia (RVSA) Implementation: Commencement of Testing Facility Approvals provisions commenced on 6 May 2020 that implement these changes.

Details can be found in the Interim arrangements guidance document, relating to specialist and enthusiast vehicles listed page 95, 96, 97, 98, 99.

The Road Vehicle Standards (RVS) legislation is replacing the Motor Vehicle Standards Act 1989 (MVSA) as part of a phased transition over the coming months.

In order to facilitate a smooth transition to the commencement of the first phase of the RVS legislation, the Department of Infrastructure, Transport, Regional Development and Communications (“the department”) conducted a targeted prototype trial in March of the testing facilities module of ROVER (the department’s new IT system that will support applications under the RVS legislation).

Following this successful prototype trial, the Deputy Prime Minister has made the necessary legislative instrument to enable the relevant provisions of the Road Vehicle Standards (RVS) legislation to commence – this instrument is available on the Federal Register of Legislation.

We are therefore pleased to confirm that applications for testing facility approvals under the RVS legislation opened from Wednesday 6 May 2020.

The aim is for a gradual progressive rollout, with further improvements slated for introduction in the coming months. 

It is important to note that, if a test facility has prepared test reports while registered in the department’s Road Vehicle Certification System (RVCS), those reports will  continue to be used to demonstrate compliance with applicable standards provided that the test facility applies for, and is granted, a testing facility approval under the RVS legislation.

Test reports from testing facilities that have been approved under the new RVS legislation will not be required until component type approval applications open in the 3rd quarter of 2020 (anticipated commencement date).

Robyn SmartUpdated Rules for Imported Disability Vehicles to Comply with Australian Standards
read more
NDIA Releases Status Tracking For Provider Enquiries

NDIA Releases Status Tracking For Provider Enquiries

No comments

The NDIA has released a new feature to the MyPlace provider portal to assist providers in tracking the status of enquiries. The following information has been copied directly from the NDIA notice via the NATA group.

As flagged in the March and April NDIA Provider eNewsletter, the NDIA has improved the payment enquiries process for providers by introducing a ‘Payment Enquiry’ tile in the MyPlace provider portal.

By submitting a payment enquiry through the MyPlace provider portal, registered providers will receive a unique identification number to track the status of the enquiry. They will also be able to view a history of all payment enquiries made through the portal.

These features are not available when lodging payment enquiry emails via the inbox.

This new functionality has been implemented as a result of feedback from providers on how to enhance the payment enquiry experience.

Providers can create a payment enquiry through the MyPlace provider portal in three steps:

  • Log into the MyPlace provider portal and click the ‘View Complaints and Enquiries’ tile.
  • Click ‘Add new request’ button.
  • Click ‘Payment enquiry’ button and begin filling in the details of your enquiry.

If you or your members have questions about the use of the ‘Payment Enquiry’ tile, please call the NDIS Contact Centre on 1800 800 110.

Please note, from 29 May 2020 the NDIA will no longer accept payment enquiries to the email inbox. We understand this will be a change of process for some providers. 

Robyn SmartNDIA Releases Status Tracking For Provider Enquiries
read more